Monkey dust is a street name for synthetic cathinones, a family of lab-made stimulant drugs chemically related to cathinone, the active compound found in the khat plant. The term most commonly refers to MDPV (methylenedioxypyrovalerone) or its close chemical relative alpha-PVP, sometimes called “flakka.” These substances gained widespread attention after a wave of alarming incidents in the UK, particularly in Stoke-on-Trent, where emergency services reported surges in erratic, sometimes violent behavior linked to the drug.
The Chemistry Behind the Street Name
MDPV was originally developed by the pharmaceutical company Boehringer Ingelheim in the mid-1960s as a potential stimulant medication, but it never reached clinical trials and was never marketed. Decades later, it resurfaced on the illicit drug market as one of the original ingredients in products sold as “bath salts.” After MDPV was banned in many countries, manufacturers pivoted to alpha-PVP, a nearly identical compound missing just one small chemical group. Both belong to a subclass called pyrrolidine cathinones, and both produce similar effects.
The powder is typically off-white or yellowish and can be surprisingly cheap, sometimes costing as little as a few pounds per dose. That low price point is one reason it has become prevalent in economically deprived areas. A typical oral dose of synthetic cathinones ranges from 25 to 75 mg, with amounts above 90 mg considered high-dose territory where serious harm becomes more likely. Because the drug is made in unregulated labs, users have no way of knowing the actual dose or purity of what they’re taking.
How People Take It
Monkey dust is most commonly snorted as a powder. It can also be swallowed, either in tablet form or wrapped in a cigarette paper (a method sometimes called “bombing”). Some users smoke it. The route of administration affects how quickly effects hit and how intense they are, with snorting and smoking producing a faster, sharper onset than swallowing.
What It Does to the Brain
Your brain uses chemical messengers called neurotransmitters, including dopamine and norepinephrine, to regulate mood, energy, attention, and the feeling of reward. Normally, after these chemicals do their job, specialized transporter proteins pull them back into the nerve cell so the signal stops. MDPV and alpha-PVP work by blocking those transporter proteins, preventing dopamine and norepinephrine from being cleared away. The result is a massive buildup of these chemicals in the spaces between nerve cells, producing an intense and prolonged stimulant high.
This mechanism is similar to how cocaine works, but MDPV is estimated to be significantly more potent at blocking dopamine reuptake. That potency is part of what makes the drug so reinforcing and so dangerous. The flood of dopamine creates powerful feelings of euphoria and energy, but it also drives compulsive redosing, where users take hit after hit in a binge pattern that dramatically increases the risk of toxic effects.
Short-Term Effects
At lower doses, monkey dust produces effects similar to MDMA or cocaine: a rush of energy, euphoria, talkativeness, and a heightened connection to music or sensory experiences. Physical side effects at this stage include enlarged pupils, muscle tension, reduced appetite, and difficulty sleeping.
At higher doses or after repeated use in a short period, the picture changes significantly. Users can experience severe paranoia, intense anxiety, stomach pain, and a rapid heart rate. The paranoia can escalate into full psychotic episodes, with hallucinations and delusional thinking that may persist for hours. News reports of people climbing buildings, running into traffic, or behaving as though they feel no pain are linked to this acute psychosis. Dangerously elevated body temperature is another serious risk, which can lead to organ damage or death if untreated.
Long-Term Health Risks
The damage from repeated synthetic cathinone use extends well beyond the brain. Research has identified four major categories of harm: neurotoxicity (brain damage), cardiotoxicity (heart damage), kidney damage, and lung damage. Autopsy findings in fatal cases have documented enlarged hearts and fluid-filled lungs consistent with severe cardiovascular stress.
The neurological effects are particularly concerning. Animal studies show that prolonged MDPV exposure causes actual neurodegeneration, meaning nerve cells in specific brain regions die off rather than simply being temporarily impaired. Researchers have documented decreased brain connectivity in areas involved in decision-making and reward processing. Repeated MDPV use has also been linked to deficits in recognition memory, with degeneration observed in the brain regions responsible for identifying familiar objects and navigating spatial environments. In severe cases, MDPV intoxication has resulted in anoxic brain injury, where the brain is starved of oxygen, leading to profound and often irreversible damage visible on brain scans.
Other synthetic cathinones in the same family have been shown to cause DNA damage in the frontal cortex and destroy dopamine and serotonin nerve terminals, the very infrastructure the brain relies on for mood regulation, motivation, and cognitive function. While much of this evidence comes from animal research, the autopsy and brain imaging findings in human cases are consistent with these results.
Legal Status
In the United Kingdom, synthetic cathinones including MDPV and alpha-PVP are currently controlled as Class B substances under the Misuse of Drugs Act. There have been public calls to reclassify monkey dust as Class A (the most serious category, alongside heroin and cocaine), though drug policy experts have argued that reclassification alone is unlikely to reduce use in communities where the drug is already entrenched. The 2016 Psychoactive Substances Act also broadly prohibits the production and supply of new psychoactive substances in the UK.
In the United States, MDPV is a Schedule I controlled substance, and alpha-PVP has also been federally scheduled. Despite these restrictions, new structural variants continue to appear on the illicit market, often tweaked just enough to temporarily skirt specific chemical bans before being caught up in broader legislation.
Why It Keeps Making Headlines
Monkey dust occupies a particular niche in the drug landscape because of the combination of extreme potency, rock-bottom price, and the visibility of its worst effects. Unlike drugs that tend to sedate users or keep them indoors, the acute psychosis triggered by high doses or binges plays out in public. Emergency responders have reported that people under its influence can be extraordinarily difficult to restrain, not because the drug grants superhuman strength, but because the psychosis and elevated body temperature suppress normal pain responses and self-preservation instincts.
The drug’s affordability also means it disproportionately affects people already in vulnerable situations, including those experiencing homelessness or severe poverty. In areas where monkey dust use has become concentrated, emergency services and hospitals bear a heavy burden, with some reporting dozens of related calls per week during peak periods.